131 related articles for article (PubMed ID: 18782650)
21. Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganin.
Cizeau J; Grenkow DM; Brown JG; Entwistle J; MacDonald GC
J Immunother; 2009; 32(6):574-84. PubMed ID: 19483652
[TBL] [Abstract][Full Text] [Related]
22. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
[TBL] [Abstract][Full Text] [Related]
23. Profiling the pattern of the human T-cell receptor γδ complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis.
Chen H; Zou M; Teng D; Hu Y; Zhang J; He W
Cell Mol Immunol; 2019 Mar; 16(3):250-259. PubMed ID: 30886423
[TBL] [Abstract][Full Text] [Related]
24. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.
Yoon SH; Lee JM; Cho HI; Kim EK; Kim HS; Park MY; Kim TG
Cancer Gene Ther; 2009 Jun; 16(6):489-97. PubMed ID: 19096447
[TBL] [Abstract][Full Text] [Related]
25. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
26. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
27. Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model.
Zuckier LS; Berkowitz EZ; Sattenberg RJ; Zhao QH; Deng HF; Scharff MD
Cancer Res; 2000 Dec; 60(24):7008-13. PubMed ID: 11156404
[TBL] [Abstract][Full Text] [Related]
28. The T-body approach: redirecting T cells with antibody specificity.
Eshhar Z
Handb Exp Pharmacol; 2008; (181):329-42. PubMed ID: 18071952
[TBL] [Abstract][Full Text] [Related]
29. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
30. Chaperonin-containing T-complex Protein 1 Subunit ζ Serves as an Autoantigen Recognized by Human Vδ2 γδ T Cells in Autoimmune Diseases.
Chen H; You H; Wang L; Zhang X; Zhang J; He W
J Biol Chem; 2016 Sep; 291(38):19985-93. PubMed ID: 27489109
[TBL] [Abstract][Full Text] [Related]
31. Characterization of complementary determinant region 3δ in human MutS homologue 2-specific γδ T cells.
Chen H; Ji X; Cui L; Zhang J; He W
Scand J Immunol; 2015 Feb; 81(2):121-8. PubMed ID: 25410477
[TBL] [Abstract][Full Text] [Related]
32. Contribution of Complementarity-Determining Region 3 of the T-Cell Receptor Vδ2 Chain to the Recognition of Aminobisphosphonates by Human γδ T-Cells.
Nishimura H; Hirokawa M; Fujishima N; Fujishima M; Miura I; Sawada K
Int J Hematol; 2004 May; 79(4):369-76. PubMed ID: 15218968
[TBL] [Abstract][Full Text] [Related]
33. Spectratype analysis of the T cell receptor δ CDR3 region of bovine γδ T cells responding to leptospira.
Herzig CT; Mailloux VL; Baldwin CL
Immunogenetics; 2015 Feb; 67(2):95-109. PubMed ID: 25502871
[TBL] [Abstract][Full Text] [Related]
34. Folate-mediated targeting of T cells to tumors.
Roy EJ; Gawlick U; Orr BA; Kranz DM
Adv Drug Deliv Rev; 2004 Apr; 56(8):1219-31. PubMed ID: 15094217
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms determining cell membrane expression of different gammadelta TCR chain pairings.
Boucontet L; Grana M; Alzari PM; Pereira P
Eur J Immunol; 2009 Jul; 39(7):1937-46. PubMed ID: 19585514
[TBL] [Abstract][Full Text] [Related]
36. In vivo application of mAb directed against the gammadelta TCR does not deplete but generates "invisible" gammadelta T cells.
Koenecke C; Chennupati V; Schmitz S; Malissen B; Förster R; Prinz I
Eur J Immunol; 2009 Feb; 39(2):372-9. PubMed ID: 19130484
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
38. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
40. gammadelta T-cell receptors: functional correlations.
O'Brien RL; Roark CL; Jin N; Aydintug MK; French JD; Chain JL; Wands JM; Johnston M; Born WK
Immunol Rev; 2007 Feb; 215():77-88. PubMed ID: 17291280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
